Copyright Reports & Markets. All rights reserved.

Global Biofunctional Peptide Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Biofunctional Peptide Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Animal
    • 1.3.3 Vegetal
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Biofunctional Peptide Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Food and Beverages
    • 1.4.3 Cosmetics
    • 1.4.4 Others
  • 1.5 Global Biofunctional Peptide Market Size & Forecast
    • 1.5.1 Global Biofunctional Peptide Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Biofunctional Peptide Sales Quantity (2020-2031)
    • 1.5.3 Global Biofunctional Peptide Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 American Peptide Company Inc.
    • 2.1.1 American Peptide Company Inc. Details
    • 2.1.2 American Peptide Company Inc. Major Business
    • 2.1.3 American Peptide Company Inc. Biofunctional Peptide Product and Services
    • 2.1.4 American Peptide Company Inc. Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 American Peptide Company Inc. Recent Developments/Updates
  • 2.2 Phermpep Co. Ltd.
    • 2.2.1 Phermpep Co. Ltd. Details
    • 2.2.2 Phermpep Co. Ltd. Major Business
    • 2.2.3 Phermpep Co. Ltd. Biofunctional Peptide Product and Services
    • 2.2.4 Phermpep Co. Ltd. Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Phermpep Co. Ltd. Recent Developments/Updates
  • 2.3 ALEXIS Corporation
    • 2.3.1 ALEXIS Corporation Details
    • 2.3.2 ALEXIS Corporation Major Business
    • 2.3.3 ALEXIS Corporation Biofunctional Peptide Product and Services
    • 2.3.4 ALEXIS Corporation Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 ALEXIS Corporation Recent Developments/Updates
  • 2.4 Merck KGaA
    • 2.4.1 Merck KGaA Details
    • 2.4.2 Merck KGaA Major Business
    • 2.4.3 Merck KGaA Biofunctional Peptide Product and Services
    • 2.4.4 Merck KGaA Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Merck KGaA Recent Developments/Updates
  • 2.5 Promega Corporation
    • 2.5.1 Promega Corporation Details
    • 2.5.2 Promega Corporation Major Business
    • 2.5.3 Promega Corporation Biofunctional Peptide Product and Services
    • 2.5.4 Promega Corporation Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Promega Corporation Recent Developments/Updates
  • 2.6 Advanced Bioconcept Company
    • 2.6.1 Advanced Bioconcept Company Details
    • 2.6.2 Advanced Bioconcept Company Major Business
    • 2.6.3 Advanced Bioconcept Company Biofunctional Peptide Product and Services
    • 2.6.4 Advanced Bioconcept Company Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Advanced Bioconcept Company Recent Developments/Updates
  • 2.7 Arlak Biotech
    • 2.7.1 Arlak Biotech Details
    • 2.7.2 Arlak Biotech Major Business
    • 2.7.3 Arlak Biotech Biofunctional Peptide Product and Services
    • 2.7.4 Arlak Biotech Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Arlak Biotech Recent Developments/Updates
  • 2.8 WN Pharmaceuticals Ltd.
    • 2.8.1 WN Pharmaceuticals Ltd. Details
    • 2.8.2 WN Pharmaceuticals Ltd. Major Business
    • 2.8.3 WN Pharmaceuticals Ltd. Biofunctional Peptide Product and Services
    • 2.8.4 WN Pharmaceuticals Ltd. Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 WN Pharmaceuticals Ltd. Recent Developments/Updates
  • 2.9 Anaspec Inc.
    • 2.9.1 Anaspec Inc. Details
    • 2.9.2 Anaspec Inc. Major Business
    • 2.9.3 Anaspec Inc. Biofunctional Peptide Product and Services
    • 2.9.4 Anaspec Inc. Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Anaspec Inc. Recent Developments/Updates
  • 2.10 Thermo Fisher Scientific
    • 2.10.1 Thermo Fisher Scientific Details
    • 2.10.2 Thermo Fisher Scientific Major Business
    • 2.10.3 Thermo Fisher Scientific Biofunctional Peptide Product and Services
    • 2.10.4 Thermo Fisher Scientific Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.11 Seagarden AS
    • 2.11.1 Seagarden AS Details
    • 2.11.2 Seagarden AS Major Business
    • 2.11.3 Seagarden AS Biofunctional Peptide Product and Services
    • 2.11.4 Seagarden AS Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Seagarden AS Recent Developments/Updates
  • 2.12 Novo Nordisk A/S
    • 2.12.1 Novo Nordisk A/S Details
    • 2.12.2 Novo Nordisk A/S Major Business
    • 2.12.3 Novo Nordisk A/S Biofunctional Peptide Product and Services
    • 2.12.4 Novo Nordisk A/S Biofunctional Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Novo Nordisk A/S Recent Developments/Updates

3 Competitive Environment: Biofunctional Peptide by Manufacturer

  • 3.1 Global Biofunctional Peptide Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Biofunctional Peptide Revenue by Manufacturer (2020-2025)
  • 3.3 Global Biofunctional Peptide Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Biofunctional Peptide by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Biofunctional Peptide Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Biofunctional Peptide Manufacturer Market Share in 2024
  • 3.5 Biofunctional Peptide Market: Overall Company Footprint Analysis
    • 3.5.1 Biofunctional Peptide Market: Region Footprint
    • 3.5.2 Biofunctional Peptide Market: Company Product Type Footprint
    • 3.5.3 Biofunctional Peptide Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Biofunctional Peptide Market Size by Region
    • 4.1.1 Global Biofunctional Peptide Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Biofunctional Peptide Consumption Value by Region (2020-2031)
    • 4.1.3 Global Biofunctional Peptide Average Price by Region (2020-2031)
  • 4.2 North America Biofunctional Peptide Consumption Value (2020-2031)
  • 4.3 Europe Biofunctional Peptide Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Biofunctional Peptide Consumption Value (2020-2031)
  • 4.5 South America Biofunctional Peptide Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Biofunctional Peptide Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Biofunctional Peptide Sales Quantity by Type (2020-2031)
  • 5.2 Global Biofunctional Peptide Consumption Value by Type (2020-2031)
  • 5.3 Global Biofunctional Peptide Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Biofunctional Peptide Sales Quantity by Application (2020-2031)
  • 6.2 Global Biofunctional Peptide Consumption Value by Application (2020-2031)
  • 6.3 Global Biofunctional Peptide Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Biofunctional Peptide Sales Quantity by Type (2020-2031)
  • 7.2 North America Biofunctional Peptide Sales Quantity by Application (2020-2031)
  • 7.3 North America Biofunctional Peptide Market Size by Country
    • 7.3.1 North America Biofunctional Peptide Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Biofunctional Peptide Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Biofunctional Peptide Sales Quantity by Type (2020-2031)
  • 8.2 Europe Biofunctional Peptide Sales Quantity by Application (2020-2031)
  • 8.3 Europe Biofunctional Peptide Market Size by Country
    • 8.3.1 Europe Biofunctional Peptide Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Biofunctional Peptide Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Biofunctional Peptide Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Biofunctional Peptide Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Biofunctional Peptide Market Size by Region
    • 9.3.1 Asia-Pacific Biofunctional Peptide Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Biofunctional Peptide Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Biofunctional Peptide Sales Quantity by Type (2020-2031)
  • 10.2 South America Biofunctional Peptide Sales Quantity by Application (2020-2031)
  • 10.3 South America Biofunctional Peptide Market Size by Country
    • 10.3.1 South America Biofunctional Peptide Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Biofunctional Peptide Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Biofunctional Peptide Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Biofunctional Peptide Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Biofunctional Peptide Market Size by Country
    • 11.3.1 Middle East & Africa Biofunctional Peptide Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Biofunctional Peptide Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Biofunctional Peptide Market Drivers
  • 12.2 Biofunctional Peptide Market Restraints
  • 12.3 Biofunctional Peptide Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Biofunctional Peptide and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Biofunctional Peptide
  • 13.3 Biofunctional Peptide Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Biofunctional Peptide Typical Distributors
  • 14.3 Biofunctional Peptide Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biofunctional Peptide market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    This report is a detailed and comprehensive analysis for global Biofunctional Peptide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Biofunctional Peptide market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Biofunctional Peptide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Biofunctional Peptide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Biofunctional Peptide market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biofunctional Peptide
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biofunctional Peptide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd., Anaspec Inc., Thermo Fisher Scientific, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Biofunctional Peptide market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Animal
    Vegetal
    Market segment by Application
    Food and Beverages
    Cosmetics
    Others
    Major players covered
    American Peptide Company Inc.
    Phermpep Co. Ltd.
    ALEXIS Corporation
    Merck KGaA
    Promega Corporation
    Advanced Bioconcept Company
    Arlak Biotech
    WN Pharmaceuticals Ltd.
    Anaspec Inc.
    Thermo Fisher Scientific
    Seagarden AS
    Novo Nordisk A/S
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Biofunctional Peptide product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Biofunctional Peptide, with price, sales quantity, revenue, and global market share of Biofunctional Peptide from 2020 to 2025.
    Chapter 3, the Biofunctional Peptide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Biofunctional Peptide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Biofunctional Peptide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Biofunctional Peptide.
    Chapter 14 and 15, to describe Biofunctional Peptide sales channel, distributors, customers, research findings and conclusion.

    Buy now